期刊文献+

新型全肝脏去细胞化流程对细胞外基质及细胞组分残留量影响的研究 被引量:1

The Effect of a Novel Whole Liver Decellularization Protocol on the Extracellular Matrix and Cell Components Residuals
下载PDF
导出
摘要 组织工程中去细胞化支架的构建,存在着保留细胞外基质和完全去除供体细胞成分的矛盾,如何评价去细胞化流程的效果是解决的关键。本研究采用以TritonX-100为主,辅助以SDS、酶学法、物理冻融法、高低渗法等方法的新型全肝脏去细胞化流程制作去细胞支架,通过免疫组化及电镜观察支架形态结构,ELISA法检测细胞外基质各组分含量,吸光度及Western-blotting法检测供体细胞组分残留量,免疫荧光法检测支架内三维循环培养诱导WBF-344细胞分化。结果表明,该流程很好的保留了胶原蛋白、层粘连蛋白、纤粘连蛋白等细胞外三维结构;氨基聚糖、HGF、VEGF等细胞外基质保存量分别达正常组织的90%及40%;基本去除残留DNA的同时,相比SF.Badylak et al.法,细胞残留组分量如GAPDH、MCH-I及HMGB-1明显下降,仅为正常组织的10%;WBF-344细胞在支架培养系统内生长良好,白蛋白表达逐渐增强。本研究成功构建了新的、较完善的去细胞化支架制作与评价体系,为干细胞分化在肝脏疾病治疗找到一种新的应用模式, There has been a conflict between preservation of extracellular matrix and reduction of donor' s cell components on decellularized scaffold production in tissue engineering. Therefore a protocol for decellularization is the key to solve this problem. We developed a novel decellularization protocol which used TritonX - 100 as a major agent for decellularizing assisted by SDS, enzymes, freeze-thaw processing, hypotonic and hypertonic solutions etc. After morphological and histological observation through immunohistochemistry and scanning electron microscope, evaluation of ECM content by ELISA, using absorbance detection and Western-blotting to test cell components residuals, and immunofluorescence after 3D perfusion culture of WBF -344 ceils in the scaffold, the results showed that, by using this new protocol, three dimensional structure like collagen, laminin, fibronectin appeared well protected, and the extracellular matrix contents of decellularized scaffold such as GAG, HGF and VEGF was 90% and 40% of normal tissue. Besides a DNA elimination, MCH-I and HMGB - 1 were only 10% of normal tissue. WBF - 344 cells grew well in the scaffold and the albumin level was rising. In conclusion, this study built a novel decellularization protocol and evaluation system, and proposed a promising application of the acellular liver scaffold in stem cell differentiation and liver disease therapy.
出处 《中国生物医学工程学报》 CAS CSCD 北大核心 2013年第1期61-69,共9页 Chinese Journal of Biomedical Engineering
基金 浙江省外科学重中之重学科经费资助
关键词 去细胞化支架 细胞外基质 细胞组分残留 循环培养 干细胞分化 decellularized scaffold extracellular matrix cell components residuals perfusion culture stemcell differentiation
  • 相关文献

参考文献16

  • 1Vorotnikova E, Mclntosh D, Dewilde A, et al. Extracellular matrix-derived products modulate endothelial and progenitor cell migration and proliferation in vitro and stimulate regenerative healing in vivo[J]. Matrix Biology, 2010, 29 (8) : 690 - 700.
  • 2Chen RN, Ho HO, Tsai YT, et al. Process development of an acellular dermal matrix (ADM) for biomedical applications[J]. Biomaterials, 2004, 25(13): 2679 -2686.
  • 3Bolland F, Korossis S, Wilshaw SP, et al. Development and characterisation of a full-thickness acellular porcine hladder matrix for tissue engineering[J]. Biomaterials, 2007 , 28 (6) : 1061 -1070.
  • 4Bader A, Schilling T, Teebken OE, et al. Tissue engineering of heart valves-human endothelial cell seeding of detergent acellularized porcine valves[J]. EurJ Cardiothorac Surg, 1998, 14 (3 ) : 279 - 284.
  • 5Petersen TH, Calle EA, Zhao L, et aZ. Tissue-Engineered Lungs for in vivo Implantation[J]. Science, 2010, 329 (5991): 538 -54!.
  • 6Ott HC, Matthiesen TS, Goh SK, et al. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart[J]. Nat Med, 2008, 14(2): 213 -22!.
  • 7Badylak SF, Weiss DJ, Caplan A, et al. Engineered whole organs and complex tissues[J]. The Lancet, 2012, 379 (9819) : 943 - 952.
  • 8B oer U, Lohrenz A, Klingenberg M, et al. The effect of detergent-based decellularization procedures on cellular proteins and immunogenicity in equine carotid artery grafts[J] . Biomaterials, 20ll, 32 (36) : 9730 - 9737.
  • 9Daly KA, Liu S, Agrawal V, et al. The host response to endotoxin-contaminated dermal matrix[J]. Tissue Engineering Part A, 2012, 18( 11 -12): 1293 -1303.
  • 10Keane TJ, Londono R, Turner NJ, et al. Consequences of ineffective decellularization of biologic scaffolds on the host response[J]. Biomaterials, 2012, 33(6): 1771-1781.

二级参考文献25

  • 1Fox IJ,Roy-Chowdhury J. Hepatocyte transplantation[J].Journal of Hepatology,2004,(06):878-886.
  • 2Strom SC,Fisher RA,Thompson MT. Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure[J].Transplantation,1997,(04):559-569.
  • 3Fox IJ,Chowdhury JR. Hepatocyte transplantation[J].American Journal of Transplantation,2004,(Suppl 6):7-13.
  • 4Perera MT,Mirza DF,Elias E. Liver transplantation:Issues for the next,20 years[J].Journal of Gastroenterology and Hepatology,2009,(Suppl 3):S124-S131.
  • 5Strom SC,Chowdhury JR,Fox IJ. Hepatocyte transplantation for the treatment of human disease[J].Seminars in Liver Disease,1999,(01):39-48.
  • 6Watanabe FD,Mullon CJ,Hewitt WR. Clinical experience with a bioartificial liver in the treatment of severe liver failure.A phase I clinical trial[J].Annals of Surgery,1997,(05):484-494.
  • 7Sussman NL,Gislason GT,Conlin CA. The Hepatix extracorporeal liver assist device:initial clinical experience[J].Artificial Organs,1994,(05):390-396.
  • 8Nyberg SL,Misra SP. Hepatocyte liver-assist systems--a clinical update[J].Mayo Clinic Proceedings,1998,(08):765-771.
  • 9Badylak SF. The extracellular matrix as a scaffold for tissue reconstruction[J].Seminars in Cell and Developmental Biology,2002,(05):377-383.
  • 10Svegliati-Baroni G,De Minicis S,Marzioni M. Hepatic fibrogenesis in response to chronic liver injury:novel insights on the role of cell-to-cell interaction and transition[J].Liver International,2008,(08):1052-1064.

共引文献2

同被引文献50

  • 1Lopez AD, Mathers CD, Ezzati M, et al. Global Burden of Disease and Risk Factors[ M]. Washington DC: The International Bank for Reconstruction and Development/The World Bank Group,2006.
  • 2Ananthanarayanan A, Narmada BC, Mo X, et al. Purpose-driven biomaterials research in liver-tissue engineering [ J 1. Trends Biotechno1,2011,29 ( 3 ) : 110-118.
  • 3Palakkan AA, Hay DC, Anil Kumar PR, et al. Liver tissue engi- neering and cell sources: issues and challenges [ J 1. Liver Int, 2013,33 (5) :666-676.
  • 4Hou YT, Ijima H, Takei T, et al. Growth factor/heparin-immobi- lized collagen gel system enhances viability of transplanted hepato- cytes and induces angiogenesis [ J]. J Biosci Bioeng, 2011,112 (3) :265-272.
  • 5Kumar A, Tripathi A, Jain S. Extracorporeal bioartificial liver for treating acute liver diseases I J 1. J Extra Corpor Technol,2011,43 (4) :195-206.
  • 6Arenas-Herrera JE, Ko IK, Atala A, et al. Deeellularization for whole organ bioengineering [ J ]. Biomed Mater, 2013,8 ( 1 ) : 014106.
  • 7Crapo PM, Gilbert TW, Badylak SF. An overview of tissue and whole organ decellu|arization processes[ J]. Biomateiials,2011,32 (12) :3233-3243.
  • 8Badylak SF, Taylor D, Uygun K. Whole-organ tissue engineering: decenularization and recellularization of three-dimensional matrix scaffolds[ J]. Annu Rev Biomed Eng,2011,13 :27-53.
  • 9Ott HC, Matthiesen TS, Goh SK, et al. Perfusion-decellularized matrix : using nature's platform to engineer a bioartificial heart[ J]. Nat Med,2008,14(2) :213-221.
  • 10Uygun BE, Soto-Gutierrez A, Yagi H, et al. Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix[ J]. Nat Med,2010,16 (7) :814- 820.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部